Leap Therapeutics, Inc. (LPTX)

NASDAQ: LPTX · IEX Real-Time Price · USD

3.270

+0.170 (5.48%)

At close: May 1, 2024, 4:00 PM

3.050

-0.220 (-6.73%)

After-hours: May 1, 2024, 6:43 PM EDT

Leap Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	84	106	45	286	134	27	29	59	-	-
Market Cap Growth	-	137.81%	-84.43%	113.18%	395.35%	-7.85%	-49.84%	-	-	-
Enterprise Value	12	34	-22	171	81	23	12	33	29	3
PE Ratio	-1.30	-1.30	-0.82	-7.05	-3.57	-0.81	-1.27	-1.96	-	-
PS Ratio	-	-	-	190.77	89.49	-	-	-	-	-
PB Ratio	1.39	1.76	0.76	2.65	2.88	-15.49	3.21	5.27	-	-
P/FCF Ratio	-2.42	-2.42	-0.91	-8.14	-5.18	-1.00	-1.13	-2.64	-	-
P/OCF Ratio	-2.42	-2.42	-0.91	-8.14	-5.17	-1.01	-1.13	-2.65	-	-
EV/Sales Ratio	-	-	-	113.99	54.22	-	-	-	-	-
EV/EBITDA Ratio	-0.42	-0.42	0.40	-4.22	-2.96	-0.69	-0.51	-1.13	-1.21	-0.23
EV/EBIT Ratio	-0.42	-0.42	0.40	-4.21	-2.96	-0.69	-0.51	-1.13	-1.21	-0.23
EV/FCF Ratio	-0.79	-0.79	0.44	-4.86	-3.14	-0.84	-0.45	-1.48	-1.16	-0.34
Debt / Equity Ratio	-	-	0.00	0.00	0.00	-0.32	-	-	-0.30	-0.04
Debt / EBITDA Ratio	-	-	0.00	0.00	-0.01	-0.02	-	-	-1.24	-0.26
Debt / FCF Ratio	-	-	-0.01	0.00	-0.01	-0.02	-	-	-1.19	-0.39
Quick Ratio	5.71	5.71	6.12	11.65	7.21	0.61	2.87	4.52	0.11	0.07
Current Ratio	5.65	5.65	6.05	11.70	7.09	0.50	2.69	4.55	0.11	0.09
Asset Turnover	0	0	0	0.02	0.03	0	0	0	0	0
Interest Coverage	-	-	-1007.31	-989.51	-704.54	-1429.57	-1215.74	-45.05	-19.79	-92.41
Return on Equity (ROE)	-133.20%	-133.20%	-70.30%	-55.40%	-84.70%	-418.10%	-210.00%	-183.80%	30.10%	100.10%
Return on Assets (ROA)	-90.90%	-90.90%	-61.90%	-49.20%	-71.10%	-196.20%	-77.60%	-122.10%	-664.30%	-48.20%
Return on Capital (ROIC)	-144.73%	-144.73%	-96.00%	-38.38%	-60.99%	2794.57%	-335.16%	-291.01%	39.03%	17.75%
Earnings Yield	-97.24%	-76.83%	-122.52%	-14.18%	-28.00%	-122.73%	-78.68%	-51.12%	-	-
FCF Yield	-52.26%	-41.29%	-110.06%	-12.29%	-19.32%	-99.59%	-88.53%	-37.87%	-	-
Buyback Yield / Dilution	-80.55%	-80.55%	-31.94%	-44.66%	-162.71%	-56.69%	-56.85%	2.45%	-	-
Total Shareholder Return	-80.55%	-80.55%	-31.94%	-44.66%	-162.71%	-56.69%	-56.85%	2.45%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).